A Phase Ib/II Study Of JS015 Combination Therapy in Advanced Solid Tumors
Clinical trial NCT06139211 · COMPLETED
Trial details
- NCT number
- NCT06139211
- Sponsor
- Shanghai Junshi Bioscience Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-12-06
- Primary completion
- 2026-05-28
- Enrollment
- 66
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.